The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Waksal Harlan since 2009.
This trader's CIK number is 1449008.
At the time of last reporting, Waksal Harlan was the Executive Chair of Lyra Therapeutics, Inc.. (stock ticker symbol LYRA).
Also see all insider trading activities at Lyra Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | KDMN | 28,600 | $96,674 | 0 | $0 | 0 | $0 |
| 2017 | KDMN | 8,707 | $20,001 | 0 | $0 | 0 | $0 |
| 2016 | KDMN | 4,000 | $26,314 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | SNT | 961,538 | $249,999 | 0 | $0 | 0 | $0 |
| 2010 | SNT | 135,779 | $0 | 0 | $0 | 0 | $0 |
| 2009 | SNT | 42,188 | $12,656 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | LYRA | 25,000 | $74,100 | 0 | $0 | 0 | $0 |
| 2022 | LYRA | 236,966 | $999,996 | 0 | $0 | 0 | $0 |
1. Kadmon Holdings, Inc. (KDMN)
2. Eloxx Pharmaceuticals, Inc. (SNT)
3. Lyra Therapeutics, Inc. (LYRA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-03-13 | KDMN | Buy | 16,000 | 2.93 | 46,816 |
| 2020-03-11 | KDMN | Buy | 12,600 | 3.96 | 49,858 |
| 2017-08-10 | KDMN | Buy | 5,000 | 2.27 | 11,335 |
| 2017-08-08 | KDMN | Buy | 3,707 | 2.34 | 8,666 |
| 2016-11-16 | KDMN | Buy | 2,000 | 6.37 | 12,734 |
| 2016-11-14 | KDMN | Buy | 2,000 | 6.79 | 13,580 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-01-06 | SNT | Buy | 961,538 | .26 | 249,999 |
| 2010-02-19 | SNT | Buy | 135,779 | .00 | 0 |
| 2009-07-29 | SNT | Buy | 42,188 | .30 | 12,656 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-11-10 | LYRA | Buy | 25,000 | 2.96 | 74,100 |
| 2022-04-12 | LYRA | Buy | 236,966 | 4.22 | 999,996 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Waksal Harlan (Executive Chair of Lyra Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.